Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

19.81
+0.67003.50%
Post-market: 19.75-0.0600-0.30%18:38 EDT
Volume:1.60M
Turnover:31.46M
Market Cap:2.53B
PE:-56.75
High:19.90
Open:18.78
Low:18.77
Close:19.14
52wk High:23.56
52wk Low:6.78
Shares:127.69M
Float Shares:115.00M
Volume Ratio:0.65
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3490
EPS(LYR):-0.3490
ROE:-5.78%
ROA:-6.40%
PB:3.18
PE(LYR):-56.75

Loading ...

10x Genomics Partners with Brigham & Women's Hospital to Advance Blood-Based Autoimmune Diagnostics

Reuters
·
Jan 12

10x Genomics Partners with Dana-Farber to Advance Single Cell Cancer Diagnostics

Reuters
·
Jan 12

10x Genomics and Cancer Research Institute Launch AI-Driven Immuno-Oncology Collaboration

Reuters
·
Jan 12

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

THOMSON REUTERS
·
Jan 12

10X Genomics Q4 prelim revenue beats on consumables unit strength

Reuters
·
Jan 12

Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and 10x Genomics (TXG)

TIPRANKS
·
Jan 12

10x Genomics posts Q4 revenue of USD 166.0 million, single cell consumables reactions sold up over 20 percent

Reuters
·
Jan 12

Press Release: 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

Dow Jones
·
Jan 12

10x Genomics (TXG) Deepens Transplant Research Ties With CareDx, But What Does It Signal Strategically?

Simply Wall St.
·
Jan 10

10x Genomics Is Maintained at Hold by TD Cowen

Dow Jones
·
Jan 08

CareDx Partners with 10x Genomics to Launch ImmuneScape Multiomics Platform

Reuters
·
Jan 07

10x Genomics to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 30, 2025

10x Genomics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Dec 22, 2025

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
Dec 16, 2025

10x Genomics : Barclays Raises Target Price to $22 From $17

THOMSON REUTERS
·
Dec 15, 2025

10x Genomics Cut to Neutral From Buy by Citigroup

Dow Jones
·
Dec 12, 2025

Citigroup Downgrades 10x Genomics to Neutral From Buy, Price Target is $18

MT Newswires Live
·
Dec 11, 2025

10x Genomics Inc : Citigroup Cuts to Neutral From Buy

THOMSON REUTERS
·
Dec 11, 2025

U.S. RESEARCH ROUNDUP-BioNTtech, GE Vernova, Synopsys

Reuters
·
Dec 11, 2025

10x Genomics (TXG): Assessing Valuation After a 36% One-Month Share Price Rebound

Simply Wall St.
·
Dec 05, 2025